| Meagan Elizabeth Tibbo, MD | |
|
5777 E Mayo Blvd, Phoenix, AZ 85054-4502 | |
| (480) 515-6296 | |
| Not Available |
| Full Name | Meagan Elizabeth Tibbo |
|---|---|
| Gender | Female |
| Speciality | Orthopedic Surgery |
| Experience | 8 Years |
| Location | 5777 E Mayo Blvd, Phoenix, Arizona |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003270687 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207X00000X | Orthopaedic Surgery | 62633 (Minnesota) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Mayo Clinic Hospital | Phoenix, AZ | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Mayo Clinic - Arizona | 7012829930 | 1395 |
News Archive
From face-lifts to facials and fillers, there's no shortage of ways to reduce the inevitable signs of aging. But there's one cosmetic procedure that most people don't think about as a tool that can make women look years younger.
Ancon Technologies, a company devoted to finding new ways to beat cancer, recently unveiled a new cancer-screening device to the public, the NBT detector. The company's latest product aims to bring cancer detection to the next level: it uses Nanoparticle Biomarker Tagging technology to identify cancer biomarkers in exhaled air.
Researchers from the Centers for Disease Control and Prevention (CDC) have conducted a study showing that face masks and neck gaiters appear to be much more effective than face shields at reducing the expulsion of respiratory aerosols that could potentially transmit severe acute respiratory syndrome 2 (SARS-CoV-2).
Use of TYRX, Inc.'s AIGISRx- Antibacterial Envelope reduced major infection rates by more than 90% in patients undergoing Cardiovascular Implantable Electronic Device replacement procedures compared to similar high-risk cohorts, according to the CITADEL & CENTURION clinical study results presented on Saturday at the Late Breaking Clinical Trials session at Heart Rhythm 2013, the Heart Rhythm Society's 34th Annual Scientific Sessions.
Repligen Corporation today announced that the Company has received $1,400,000 in research funding from the Muscular Dystrophy Association ("MDA") to support the ongoing development of RG3039 for Spinal Muscular Atrophy ("SMA"). RG3039, our lead compound, is an inhibitor of an RNA processing enzyme which targets increased production of SMN, a protein of deficient levels in patients with SMA.
› Verified 2 days ago
| Entity Name | Mayo Clinic Arizona |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1558332494 PECOS PAC ID: 7012829930 Enrollment ID: O20031105000782 |
News Archive
From face-lifts to facials and fillers, there's no shortage of ways to reduce the inevitable signs of aging. But there's one cosmetic procedure that most people don't think about as a tool that can make women look years younger.
Ancon Technologies, a company devoted to finding new ways to beat cancer, recently unveiled a new cancer-screening device to the public, the NBT detector. The company's latest product aims to bring cancer detection to the next level: it uses Nanoparticle Biomarker Tagging technology to identify cancer biomarkers in exhaled air.
Researchers from the Centers for Disease Control and Prevention (CDC) have conducted a study showing that face masks and neck gaiters appear to be much more effective than face shields at reducing the expulsion of respiratory aerosols that could potentially transmit severe acute respiratory syndrome 2 (SARS-CoV-2).
Use of TYRX, Inc.'s AIGISRx- Antibacterial Envelope reduced major infection rates by more than 90% in patients undergoing Cardiovascular Implantable Electronic Device replacement procedures compared to similar high-risk cohorts, according to the CITADEL & CENTURION clinical study results presented on Saturday at the Late Breaking Clinical Trials session at Heart Rhythm 2013, the Heart Rhythm Society's 34th Annual Scientific Sessions.
Repligen Corporation today announced that the Company has received $1,400,000 in research funding from the Muscular Dystrophy Association ("MDA") to support the ongoing development of RG3039 for Spinal Muscular Atrophy ("SMA"). RG3039, our lead compound, is an inhibitor of an RNA processing enzyme which targets increased production of SMN, a protein of deficient levels in patients with SMA.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Meagan Elizabeth Tibbo, MD 5777 E Mayo Blvd, Phoenix, AZ 85054-4502 Ph: (480) 515-6296 | Meagan Elizabeth Tibbo, MD 5777 E Mayo Blvd, Phoenix, AZ 85054-4502 Ph: (480) 515-6296 |
News Archive
From face-lifts to facials and fillers, there's no shortage of ways to reduce the inevitable signs of aging. But there's one cosmetic procedure that most people don't think about as a tool that can make women look years younger.
Ancon Technologies, a company devoted to finding new ways to beat cancer, recently unveiled a new cancer-screening device to the public, the NBT detector. The company's latest product aims to bring cancer detection to the next level: it uses Nanoparticle Biomarker Tagging technology to identify cancer biomarkers in exhaled air.
Researchers from the Centers for Disease Control and Prevention (CDC) have conducted a study showing that face masks and neck gaiters appear to be much more effective than face shields at reducing the expulsion of respiratory aerosols that could potentially transmit severe acute respiratory syndrome 2 (SARS-CoV-2).
Use of TYRX, Inc.'s AIGISRx- Antibacterial Envelope reduced major infection rates by more than 90% in patients undergoing Cardiovascular Implantable Electronic Device replacement procedures compared to similar high-risk cohorts, according to the CITADEL & CENTURION clinical study results presented on Saturday at the Late Breaking Clinical Trials session at Heart Rhythm 2013, the Heart Rhythm Society's 34th Annual Scientific Sessions.
Repligen Corporation today announced that the Company has received $1,400,000 in research funding from the Muscular Dystrophy Association ("MDA") to support the ongoing development of RG3039 for Spinal Muscular Atrophy ("SMA"). RG3039, our lead compound, is an inhibitor of an RNA processing enzyme which targets increased production of SMN, a protein of deficient levels in patients with SMA.
› Verified 2 days ago
Dr. Eric N Novack, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 2902 W Agua Fria Fwy Ste 1090, Phoenix, AZ 85027 Phone: 602-648-5444 Fax: 602-772-3801 | |
Laura Vogel Abernathie, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 2222 E Highland Ave Ste 300, Phoenix, AZ 85016 Phone: 602-277-6211 Fax: 866-846-8709 | |
Dr. John Anthony Soscia, M.D. Orthopedic Surgery Medicare: Not Enrolled in Medicare Practice Location: 9225 N 3rd St, Suite 302, Phoenix, AZ 85020 Phone: 602-944-4949 Fax: 602-944-7357 | |
Dr. Todd A Kile, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 5779 E Mayo Blvd, Phoenix, AZ 85054 Phone: 480-301-8000 | |
Dr. Delwyn J Worthington, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 3033 N 44th St Ste 100, Phoenix, AZ 85018 Phone: 602-631-3161 Fax: 602-631-3162 | |
Dr. Kishore Tipirneni, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 19636 N 27th Ave Ste 401, Phoenix, AZ 85027 Phone: 602-298-8888 Fax: 602-978-4129 |